SCARB1 and chronic kidney disease: Plasma-advanced oxidation products [41] and hepatic scavenger receptor-B1 (SRB1) suppression affect the clearance of HDL-C in CKD [42] and could explain the increased large HDL particle concentrations and HDL size linked to increased CV events in our study, similar to patients on dialysis [33].